期刊
TOXICOLOGICAL SCIENCES
卷 140, 期 2, 页码 445-461出版社
OXFORD UNIV PRESS
DOI: 10.1093/toxsci/kfu084
关键词
cardiotoxicity; multi-electrode array; preclinical; proarrhythmia; stem cells; cardiomyocyte
类别
Human stem cell derived cardiomyocytes (hESC-CM) provide a potential model for development of improved assays for preclinical predictive drug safety screening. We have used multi-electrode array (MEA) analysis of hESC-CM to generate multi-parameter data to profile drug impact on cardiomyocyte electrophysiology using a panel of 21 compounds active against key cardiac ion channels. Our study is the first to apply multi-parameter phenotypic profiling and clustering techniques commonly used for high-content imaging and microarray data to the analysis of electrophysiology data obtained by MEA analysis. Our data show good correlations with previous studies in stem cell derived cardiomyocytes and demonstrate improved specificity in compound risk assignment over convention single-parametric approaches. These analyses indicate great potential for multi-parameter MEA data acquired from hESC-CM to enable drug electrophysiological liabilities to be assessed in pre-clinical cardiotoxicity assays, facilitating informed decision making and liability management at the optimum point in drug development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据